Literature DB >> 16368107

BCL-XL dimerization by three-dimensional domain swapping.

Jason W O'Neill1, Michael K Manion, Brendan Maguire, David M Hockenbery.   

Abstract

Dimeric interactions among anti- and pro-apoptotic members of the BCL-2 protein family are dynamically regulated and intimately involved in survival and death functions. We report the structure of a BCL-X(L) homodimers a 3D-domain swapped dimer (3DDS). The X-ray crystal structure demonstrates the mutual exchange of carboxy-terminal regions including BH2 (Bcl-2 homology 2) between monomer subunits, with the hinge region occurring at the hairpin turn between the fifth and sixth alpha helices. Both BH3 peptide-binding hydrophobic grooves are unoccupied in the 3DDS dimer and available for BH3 peptide binding, as confirmed by sedimentation velocity analysis. BCL-X(L) 3DDS dimers have increased pore-forming activity compared to monomers, suggesting that 3DDS dimers may act as intermediates in membrane pore formation. Chemical crosslinking studies of Cys-substituted BCL-X(L) proteins demonstrate that 3DDS dimers form in synthetic lipid vesicles.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16368107     DOI: 10.1016/j.jmb.2005.11.032

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  44 in total

1.  Bcl-2 and Bax interact via the BH1-3 groove-BH3 motif interface and a novel interface involving the BH4 motif.

Authors:  Jingzhen Ding; Zhi Zhang; G Jane Roberts; Mina Falcone; Yiwei Miao; Yuanlong Shao; Xuejun C Zhang; David W Andrews; Jialing Lin
Journal:  J Biol Chem       Date:  2010-06-28       Impact factor: 5.157

2.  The C. elegans B-cell lymphoma 2 (Bcl-2) homolog cell death abnormal 9 (CED-9) associates with and remodels LIPID membranes.

Authors:  Frederick J Tan; Jonathan E Zuckerman; Robert C Wells; R Blake Hill
Journal:  Protein Sci       Date:  2011-01       Impact factor: 6.725

3.  tBid elicits a conformational alteration in membrane-bound Bcl-2 such that it inhibits Bax pore formation.

Authors:  Jun Peng; Chibing Tan; G Jane Roberts; Olga Nikolaeva; Zhi Zhang; Suzanne M Lapolla; Steve Primorac; David W Andrews; Jialing Lin
Journal:  J Biol Chem       Date:  2006-09-27       Impact factor: 5.157

4.  Organization of the mitochondrial apoptotic BAK pore: oligomerization of the BAK homodimers.

Authors:  Sreevidya Aluvila; Tirtha Mandal; Eric Hustedt; Peter Fajer; Jun Yong Choe; Kyoung Joon Oh
Journal:  J Biol Chem       Date:  2013-12-11       Impact factor: 5.157

Review 5.  The rheostat in the membrane: BCL-2 family proteins and apoptosis.

Authors:  N Volkmann; F M Marassi; D D Newmeyer; D Hanein
Journal:  Cell Death Differ       Date:  2013-10-25       Impact factor: 15.828

6.  Molecular details of Bax activation, oligomerization, and membrane insertion.

Authors:  Stephanie Bleicken; Mirjam Classen; Pulagam V L Padmavathi; Takashi Ishikawa; Kornelius Zeth; Heinz-Jürgen Steinhoff; Enrica Bordignon
Journal:  J Biol Chem       Date:  2009-12-12       Impact factor: 5.157

7.  Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis.

Authors:  Grant Dewson; Ruth M Kluck
Journal:  J Cell Sci       Date:  2009-08-15       Impact factor: 5.285

Review 8.  Connecting mitochondrial dynamics and life-or-death events via Bcl-2 family proteins.

Authors:  Abdel Aouacheria; Stephen Baghdiguian; Heather M Lamb; Jason D Huska; Fernando J Pineda; J Marie Hardwick
Journal:  Neurochem Int       Date:  2017-04-28       Impact factor: 3.921

9.  Evidence that membrane insertion of the cytosolic domain of Bcl-xL is governed by an electrostatic mechanism.

Authors:  Guruvasuthevan R Thuduppathy; Jeffrey W Craig; Victoria Kholodenko; Arne Schon; R Blake Hill
Journal:  J Mol Biol       Date:  2006-04-06       Impact factor: 5.469

10.  Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein.

Authors:  Samantha Cooray; Mohammad W Bahar; Nicola G A Abrescia; Colin E McVey; Nathan W Bartlett; Ron A-J Chen; David I Stuart; Jonathan M Grimes; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2007-06       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.